Solid Bio
Solid Bio is a Massachusetts-based life sciences company that develops novel therapeutics for the treatment of Duchenne muscular dystrophy.
Business Model:
Revenue: $11.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Solid Bio Information
Geographic Data
Address: 500 Rutherford Avenue
City: Charlestown
State: MA
Zip: 02129
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$144M
Raised Total:$366M
Social
Metrics
3,358,032Website Global Rank
4,417Website Monthly Traffic
Twitter Followers
Description
Solid Bio is a Massachusetts-based life sciences company that develops novel therapeutics for the treatment of Duchenne muscular dystrophy.
Contact Phone:
+16173374680
Contact Email:
Solid Bio went public on 1/26/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/26/2018
IPO Valuation:
$546M
Ticker Symbol:
SLDB
IPO Price:
$16/share
Amount Raised:
$125M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
